Yamashita, Y., Hori, Y., Kosako, H., Oiwa, T., Warigaya, K., Mushino, T., Murata, S., Fujimoto, M., Nishikawa, A., Murata, S.- ichi, Sonoki, T., & Tamura, S. (2020). Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with <em>RUNX3</em&gt; overexpression. Hematology Reports, 12(1). https://doi.org/10.4081/hr.2020.8368